SpecStream

Data / Form D filings / J3 BIOSCIENCE, INC.

J3 BIOSCIENCE, INC.: Form D filing

J3 BIOSCIENCE, INC., a health care company in Salt Lake City, UT, filed a Form D with the SEC in 2026. The latest, on October 16, 2026, reports $50,000 sold of a $50,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
825 NORTH 300 WEST SUITE N231, Salt Lake City, UT, 84103
Phone
(801) 931-4756
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Utah
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1408012

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 16New notice$50,000$50,0001Sep 30sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Duck Joo LeeExecutive Officer, Director
Tim S GlassettExecutive Officer, Director
R Tyler McCabeExecutive Officer, Director
Stath J KarrasDirector
Sheryl A KingsbergDirector
Troy E MasonDirector
Ron E NielsenDirector
Keith A MarmerDirector
Stephanie M SingerDirector

Other health care companies in Utah that filed recently

Every Form D from the week of Oct 12 · All recent filings in Utah · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what J3 BIOSCIENCE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.